Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the third international workshop

Richard Eastell, A. Arnold, M. L. Brandi, E. M. Brown, P. D'Amour, D. A. Hanley, D. Sudhaker Rao, M. R. Rubin, D. Goltzman, S. J. Silverberg, S. J. Marx, Munro Peacock, L. Mosekilde, R. Bouillon, E. M. Lewiecki

Research output: Contribution to journalArticle

216 Citations (Scopus)

Abstract

Objective: Asymptomatic primary hyperparathyroidism (PHPT) is a common clinical problem. The purpose of this report is to guide the use of diagnostic tests for this condition in clinical practice. Participants: Interested professional societies selected a representative for the consensus committee and provided funding for a one-day meeting. A subgroup of this committee set the program and developed key questions for review. Consensus was established at a closed meeting that followed. The conclusions were then circulated to the participating professional societies. Evidence: Each question was addressed by a relevant literature search (on PubMed), and the data were presented for discussion at the group meeting. Consensus Process: Consensus was achieved by a group meeting. Statements were prepared by all authors, with comments relating to accuracy from the diagnosis subgroup and by representatives from the participating professional societies. Conclusions: We conclude that: 1) reference ranges should be established for serum PTH in vitamin D-replete healthy individuals; 2) second- and third-generation PTH assays are both helpful in the diagnosis of PHPT; 3) DNA sequence testing can be useful in familial hyperparathyroidism or hypercalcemia; 4) normocalcemic PHPT is a variant of the more common presentation of PHPT with hypercalcemia; 5) serum 25-hydroxyvitamin D levels should be measured and, if vitamin D insufficiency is present, it should be treated as part of any management course; and 6) the estimated glomerular filtration rate should be used to determine the level of kidney function in PHPT: an estimated glomerular filtration rate of less than 60 ml/min·1.73 m2 should be a benchmark for decisions about surgery in established asymptomatic PHPT.

Original languageEnglish
Pages (from-to)340-350
Number of pages11
JournalJournal of Clinical Endocrinology and Metabolism
Volume94
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Primary Hyperparathyroidism
Education
Vitamin D
Consensus
Group Processes
DNA sequences
Hypercalcemia
Glomerular Filtration Rate
Surgery
Assays
Benchmarking
Hyperparathyroidism
Testing
Serum
Routine Diagnostic Tests
PubMed
Reference Values
Kidney

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Eastell, R., Arnold, A., Brandi, M. L., Brown, E. M., D'Amour, P., Hanley, D. A., ... Lewiecki, E. M. (2009). Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the third international workshop. Journal of Clinical Endocrinology and Metabolism, 94(2), 340-350. https://doi.org/10.1210/jc.2008-1758

Diagnosis of asymptomatic primary hyperparathyroidism : Proceedings of the third international workshop. / Eastell, Richard; Arnold, A.; Brandi, M. L.; Brown, E. M.; D'Amour, P.; Hanley, D. A.; Sudhaker Rao, D.; Rubin, M. R.; Goltzman, D.; Silverberg, S. J.; Marx, S. J.; Peacock, Munro; Mosekilde, L.; Bouillon, R.; Lewiecki, E. M.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 94, No. 2, 02.2009, p. 340-350.

Research output: Contribution to journalArticle

Eastell, R, Arnold, A, Brandi, ML, Brown, EM, D'Amour, P, Hanley, DA, Sudhaker Rao, D, Rubin, MR, Goltzman, D, Silverberg, SJ, Marx, SJ, Peacock, M, Mosekilde, L, Bouillon, R & Lewiecki, EM 2009, 'Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the third international workshop', Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, pp. 340-350. https://doi.org/10.1210/jc.2008-1758
Eastell, Richard ; Arnold, A. ; Brandi, M. L. ; Brown, E. M. ; D'Amour, P. ; Hanley, D. A. ; Sudhaker Rao, D. ; Rubin, M. R. ; Goltzman, D. ; Silverberg, S. J. ; Marx, S. J. ; Peacock, Munro ; Mosekilde, L. ; Bouillon, R. ; Lewiecki, E. M. / Diagnosis of asymptomatic primary hyperparathyroidism : Proceedings of the third international workshop. In: Journal of Clinical Endocrinology and Metabolism. 2009 ; Vol. 94, No. 2. pp. 340-350.
@article{36cf155f9d3e47f1b78d948ef044dc07,
title = "Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the third international workshop",
abstract = "Objective: Asymptomatic primary hyperparathyroidism (PHPT) is a common clinical problem. The purpose of this report is to guide the use of diagnostic tests for this condition in clinical practice. Participants: Interested professional societies selected a representative for the consensus committee and provided funding for a one-day meeting. A subgroup of this committee set the program and developed key questions for review. Consensus was established at a closed meeting that followed. The conclusions were then circulated to the participating professional societies. Evidence: Each question was addressed by a relevant literature search (on PubMed), and the data were presented for discussion at the group meeting. Consensus Process: Consensus was achieved by a group meeting. Statements were prepared by all authors, with comments relating to accuracy from the diagnosis subgroup and by representatives from the participating professional societies. Conclusions: We conclude that: 1) reference ranges should be established for serum PTH in vitamin D-replete healthy individuals; 2) second- and third-generation PTH assays are both helpful in the diagnosis of PHPT; 3) DNA sequence testing can be useful in familial hyperparathyroidism or hypercalcemia; 4) normocalcemic PHPT is a variant of the more common presentation of PHPT with hypercalcemia; 5) serum 25-hydroxyvitamin D levels should be measured and, if vitamin D insufficiency is present, it should be treated as part of any management course; and 6) the estimated glomerular filtration rate should be used to determine the level of kidney function in PHPT: an estimated glomerular filtration rate of less than 60 ml/min·1.73 m2 should be a benchmark for decisions about surgery in established asymptomatic PHPT.",
author = "Richard Eastell and A. Arnold and Brandi, {M. L.} and Brown, {E. M.} and P. D'Amour and Hanley, {D. A.} and {Sudhaker Rao}, D. and Rubin, {M. R.} and D. Goltzman and Silverberg, {S. J.} and Marx, {S. J.} and Munro Peacock and L. Mosekilde and R. Bouillon and Lewiecki, {E. M.}",
year = "2009",
month = "2",
doi = "10.1210/jc.2008-1758",
language = "English",
volume = "94",
pages = "340--350",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Diagnosis of asymptomatic primary hyperparathyroidism

T2 - Proceedings of the third international workshop

AU - Eastell, Richard

AU - Arnold, A.

AU - Brandi, M. L.

AU - Brown, E. M.

AU - D'Amour, P.

AU - Hanley, D. A.

AU - Sudhaker Rao, D.

AU - Rubin, M. R.

AU - Goltzman, D.

AU - Silverberg, S. J.

AU - Marx, S. J.

AU - Peacock, Munro

AU - Mosekilde, L.

AU - Bouillon, R.

AU - Lewiecki, E. M.

PY - 2009/2

Y1 - 2009/2

N2 - Objective: Asymptomatic primary hyperparathyroidism (PHPT) is a common clinical problem. The purpose of this report is to guide the use of diagnostic tests for this condition in clinical practice. Participants: Interested professional societies selected a representative for the consensus committee and provided funding for a one-day meeting. A subgroup of this committee set the program and developed key questions for review. Consensus was established at a closed meeting that followed. The conclusions were then circulated to the participating professional societies. Evidence: Each question was addressed by a relevant literature search (on PubMed), and the data were presented for discussion at the group meeting. Consensus Process: Consensus was achieved by a group meeting. Statements were prepared by all authors, with comments relating to accuracy from the diagnosis subgroup and by representatives from the participating professional societies. Conclusions: We conclude that: 1) reference ranges should be established for serum PTH in vitamin D-replete healthy individuals; 2) second- and third-generation PTH assays are both helpful in the diagnosis of PHPT; 3) DNA sequence testing can be useful in familial hyperparathyroidism or hypercalcemia; 4) normocalcemic PHPT is a variant of the more common presentation of PHPT with hypercalcemia; 5) serum 25-hydroxyvitamin D levels should be measured and, if vitamin D insufficiency is present, it should be treated as part of any management course; and 6) the estimated glomerular filtration rate should be used to determine the level of kidney function in PHPT: an estimated glomerular filtration rate of less than 60 ml/min·1.73 m2 should be a benchmark for decisions about surgery in established asymptomatic PHPT.

AB - Objective: Asymptomatic primary hyperparathyroidism (PHPT) is a common clinical problem. The purpose of this report is to guide the use of diagnostic tests for this condition in clinical practice. Participants: Interested professional societies selected a representative for the consensus committee and provided funding for a one-day meeting. A subgroup of this committee set the program and developed key questions for review. Consensus was established at a closed meeting that followed. The conclusions were then circulated to the participating professional societies. Evidence: Each question was addressed by a relevant literature search (on PubMed), and the data were presented for discussion at the group meeting. Consensus Process: Consensus was achieved by a group meeting. Statements were prepared by all authors, with comments relating to accuracy from the diagnosis subgroup and by representatives from the participating professional societies. Conclusions: We conclude that: 1) reference ranges should be established for serum PTH in vitamin D-replete healthy individuals; 2) second- and third-generation PTH assays are both helpful in the diagnosis of PHPT; 3) DNA sequence testing can be useful in familial hyperparathyroidism or hypercalcemia; 4) normocalcemic PHPT is a variant of the more common presentation of PHPT with hypercalcemia; 5) serum 25-hydroxyvitamin D levels should be measured and, if vitamin D insufficiency is present, it should be treated as part of any management course; and 6) the estimated glomerular filtration rate should be used to determine the level of kidney function in PHPT: an estimated glomerular filtration rate of less than 60 ml/min·1.73 m2 should be a benchmark for decisions about surgery in established asymptomatic PHPT.

UR - http://www.scopus.com/inward/record.url?scp=59749089672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59749089672&partnerID=8YFLogxK

U2 - 10.1210/jc.2008-1758

DO - 10.1210/jc.2008-1758

M3 - Article

C2 - 19193909

AN - SCOPUS:59749089672

VL - 94

SP - 340

EP - 350

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 2

ER -